← All companies

HEPA

Hepion Pharmaceuticals, Inc.

HEPA OTC Pharmaceutical Preparations EDGAR ↗

$0.07

+0.03 +56.52%

Key statistics

from XBRL data in SEC filings

Market cap

$2.10M

Revenue (TTM)

$0.00

Net income (TTM)

-$2.98M

EPS (TTM)

$1.20

P/E ratio

0.1

Dividend yield

—

Free cash flow

-$3.29M

Cash

$2.60M

Total assets

$2.71M

Gross margin

—

52-week range

$0.03 – $0.11

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 2, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity Apr 22, 2026 8-K Entered a material agreement; Director or officer change Apr 14, 2026 8-K Director or officer change Mar 18, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Entered a material agreement; Other events Mar 3, 2026 8-K Director or officer change Jan 15, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change Jun 30, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Director or officer change Jun 9, 2025 8-K Entered a material agreement May 30, 2025 10-Q Quarter ended 2025-03-31 May 19, 2025 8-K Delisting notice or listing-rule failure May 12, 2025 8-K Entered a material agreement; Unregistered sale of equity May 6, 2025 8-K Delisting notice or listing-rule failure Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Apr 8, 2025 8-K/A Other events Apr 4, 2025 8-K Delisting notice or listing-rule failure Mar 20, 2025 8-K Modified rights of security holders; Amended charter or bylaws Mar 19, 2025 8-K Shareholder vote results Mar 10, 2025 8-K Other events Mar 4, 2025 8-K Delisting notice or listing-rule failure Jan 15, 2025 10-K/A Fiscal year ended 2023-12-31 Jan 13, 2025 8-K Terminated a material agreement; Other events Dec 11, 2024 8-K Delisting notice or listing-rule failure Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Delisting notice or listing-rule failure Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change Aug 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Jul 22, 2024 10-K/A Fiscal year ended 2023-12-31 Jun 25, 2024 10-Q Quarter ended 2024-03-31 May 21, 2024 10-K Fiscal year ended 2023-12-31 Apr 16, 2024 8-K Director or officer change Mar 6, 2024 8-K Director or officer change Feb 20, 2024 8-K Entered a material agreement; Unregistered sale of equity Feb 16, 2024